Whole Exome Sequencing
Whole Exome Sequencing (WES) offers advantages as a viable and cost-effective alternative for Whole Genome Sequencing. With the development of precision medicine, WES is utilized more and more frequently in patient cases where the diagnoses or treatment options are unclear.
Features and Advantages
Agilent SureSelect Human All Exon v6 and v8 avaliable
Guaranteed data quality at competitive pricing
Experienced pre-sales and after-sales support
Strict and standardized project management and QC system to guarantee project quality
Sequencing Standards
PE100 or PE150
Guaranteed ≥ 80% of bases with quality score of ≥Q30
- Standard sequencing coverage ≥100X; ≥200X is recommended for cancer samples
Sampling Requirements
Regular Samples
Intact genomic DNA: ≥ 500 ng
Concentration: ≥ 12.5 ng/µL
Volume: 15 µL
Low Input Samples
Genomic DNA: ≥ 100 ng
Concentration: ≥ 2.5 ng/µL
Volume: 15 µL
Service Details
Typical 18 working days from sample QC acceptance to data availability
Expedited services are available, contact your local representative for details
- Reports and output data files are delivered in industry standard file formats: BAM, .xls, .png and FASTQ data
Related materials
If you want more information？
Consult us now!
